138 related articles for article (PubMed ID: 8470423)
1. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients.
Lefebure AF; Verpooten GA; Couttenye MM; De Broe ME
Vaccine; 1993; 11(4):397-9. PubMed ID: 8470423
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients.
Choy BY; Peiris JS; Chan TM; Lo SK; Lui SL; Lai KN
Am J Transplant; 2002 Nov; 2(10):965-9. PubMed ID: 12482150
[TBL] [Abstract][Full Text] [Related]
3. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
4. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
[TBL] [Abstract][Full Text] [Related]
5. Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation.
Duca P; Del Pont JM; D'Agostino D
J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):168-70. PubMed ID: 11321387
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of 20 micrograms of recombinant DNA hepatitis B vaccine in healthy neonates: a comparison of three different vaccination schemes.
del Canho R; Grosheide PM; Voogd M; Huisman WM; Heijtink RA; Schalm SW
J Med Virol; 1993 Sep; 41(1):30-4. PubMed ID: 8228934
[TBL] [Abstract][Full Text] [Related]
7. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
[TBL] [Abstract][Full Text] [Related]
8. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
9. Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance.
Clemens R; Sänger R; Kruppenbacher J; Höbel W; Stanbury W; Bock HL; Jilg W
Vaccine; 1997 Mar; 15(4):349-52. PubMed ID: 9141203
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a recombinant DNA hepatitis B vaccine in a vaccinated Nigerian population.
Adoga MP; Pennap G; Akande BO; Mairiga JP; Pechulano S; Agwale SM
J Infect Dev Ctries; 2010 Nov; 4(11):740-4. PubMed ID: 21252452
[TBL] [Abstract][Full Text] [Related]
11. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.
Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Deceuninck G; Massé R; Duval B
Hum Vaccin; 2010 Feb; 6(2):212-8. PubMed ID: 19946212
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.
Baldy JL; de Lima GZ; Morimoto HK; Reiche EM; Matsuo T; de Mattos ED; Sudan LC
Rev Inst Med Trop Sao Paulo; 2004; 46(2):103-7. PubMed ID: 15141282
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.
Das K; Gupta RK; Kumar V; Kar P
World J Gastroenterol; 2003 May; 9(5):1132-4. PubMed ID: 12717874
[TBL] [Abstract][Full Text] [Related]
14. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
[TBL] [Abstract][Full Text] [Related]
16. Long-term immunogenicity and efficacy of a recombinant hepatitis B vaccine in Egyptian children.
el-Sawy IH; Mohamed ON
East Mediterr Health J; 1999 Sep; 5(5):922-32. PubMed ID: 10983531
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccine booster dose: low-dose recombinant hepatitis B vaccines as a booster dose.
Bryan JP; MacArthy P; Rudock A; Fogarty JP; Dowd H; Legters LJ; Perine PL
Am J Infect Control; 1997 Jun; 25(3):215-22. PubMed ID: 9202817
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers.
Williams JL; Christensen CJ; McMahon BJ; Bulkow LR; Cagle HH; Mayers JS; Zanis CL; Parkinson AJ; Margolis HS
Vaccine; 2001 Jul; 19(28-29):4081-5. PubMed ID: 11427285
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates.
Bassily S; Kotkat A; Gray G; Hyams KC; Brown FM; Imam IZ; Arthur R
Am J Trop Med Hyg; 1995 Oct; 53(4):419-22. PubMed ID: 7485697
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
Rey D; Piroth L; Wendling MJ; Miailhes P; Michel ML; Dufour C; Haour G; Sogni P; Rohel A; Ajana F; Billaud E; Molina JM; Launay O; Carrat F;
Lancet Infect Dis; 2015 Nov; 15(11):1283-91. PubMed ID: 26257021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
